Skip to content
Search

Latest Stories

A new centre launched in northeast England to deliver innovative model of care

LloydsPharmacy Clinical Homecare (LCPH) has launched a new centre in Westerhope, in  partnership with Newcastle upon Tyne Hospitals NHS Foundation Trust, to deliver an innovative model of care.

The new centre provides injection and infusion services patients, while supporting the NHS by increasing capacity and taking care away from a hospital setting.


Patients, in turn, get flexibility, convenience and choice to take ownership of their treatment journey.

LPCH says the service at its fourth healthcare centre operates five days a week, and delivers approximately 14 patient treatments each day, with the capacity to reach 20.

The centre runs in partnership with global pharmaceutical companies MSD and Bristol Myers Squibb, who manufacture the medication with which the patients are treated.

LPHS claims that so far it has helped NHS Trusts release 4,707 nursing hours.

Commenting on the launch of the new centre, Nick Davis, CEO of LloydsPharmacy Clinical Homecare, said the clinic represented "a fantastic alternative treatment pathway for so many patients", particularly those that didn't have easy access to such an option.

“Equally, it’s also about generating financially efficient solutions for the NHS, and creating much-needed capacity in NHS hospitals and clinics, so that they can also service more patients.”

More For You

Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less